Torino v. Cruz

82 Misc. 2d 684, 369 N.Y.S.2d 291
CourtNew York City Family Court
DecidedMay 27, 1975
StatusPublished
Cited by3 cases

This text of 82 Misc. 2d 684 (Torino v. Cruz) is published on Counsel Stack Legal Research, covering New York City Family Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Torino v. Cruz, 82 Misc. 2d 684, 369 N.Y.S.2d 291 (N.Y. Super. Ct. 1975).

Opinion

Felice K. Shea, J.

In this paternity proceeding pursuant to article 5 of the Family Court Act the court must decide what legal effect to give conflicting blood grouping test reports, only one of which excludes respondent as the father of petitioner’s out-of-wedlock child.

In New York, the report of a nonexclusionary blood grouping test is not admissible into evidence to prove paternity, on the theory that the probative value of such a report is not great enough to counterbalance its possible prejudicial effect. (Family Ct. Act, §§418, 532.)1 On the other hand, in the absence of contradictory evidence, New York courts give conclusive weight to an exclusionary blood grouping test. (Clark v Rysedorph, 281 App Div 121; "C.” v "C.”, 200 Misc 631; Cuneo v Cuneo, 198 Misc 240; "Saks” v "Saks”, 189 Misc 667.)

BLOOD GROUPING TESTS

The instant paternity petition was filed in July, 1971. Re[686]*686spondent denied that he was the father of petitioner’s infant, and requested a blood grouping test, which was performed by Dr. Robert L. Rosenthal. A report dated November 18, 1971 was sent to this court in which Dr. Rosenthal listed the tests performed and the results obtained, and in which he stated: "Paternity is excluded by the MN groupings.”2

On January 12, 1972, the court ordered a second blood grouping test at the request of the Assistant Corporation Counsel who represented the petitioner. Respondent was present without counsel and the record does not reveal any objection made by him.3 The results of this second blood test, performed by Dr. Alexander S. Wiener, were nonexclusionary. Dr. Wiener found the child’s blood to be positive for the factor N, whereas Dr. Rosenthal’s test had shown the child’s blood to be negative for the factor N.4

Thereafter, in April, 1972, respondent’s attorney requested that a third blood grouping test be made by yet a different doctor selected from the court’s list,5 and pursuant to court [687]*687order, Dr. Richard E. Rosenfield performed a blood grouping test which again failed to exclude respondent.

On May 16, 1972, the court ordered a fourth test. The report of this final test was signed by both Dr. Rosenthal and Dr. Rosenfield and did not exclude respondent as the possible father of petitioner’s child. The report, dated October 21, 1974, stated, in part: "2. If weak but otherwise satisfactory anti-N reagents are used, the child types as M which, on the basis of a two allele genetic hypothesis, would exclude the type N putative father. We used four examples of rabbit anti-N and all four weakly distinguished the child from normal type M control blood. Two weaker rabbit anti-N, and an extract of vicia gramínea seeds, did not distinguish the child from normal type M. Nonetheless, the child must be considered as type MN2. This does not exclude the putative father because he could be N/N2.”

When the matter came on for hearing, this court, upon stipulation of the parties, admitted into evidence the results of all the blood tests performed and heard expert testimony for the purpose of determining whether or not respondent could be adjudged excluded.

Dr. Robert L. Rosenthal testified that he has been licensed to practice medicine since 1947; that he is a hematologist affiliated with Mount Sinai and Queens General Hospitals; and that he is in charge of the hematology department at Joint Diseases Hospital as well as associate clinical professor at Mount Sinai Hospital. Dr. Rosenthal testified that he performs between 150 and 200 blood grouping tests per year, many by order of the Family Court, and that he has been performing such tests for more than 20 years. Dr. Rosenthal described the testing methods he uses and the precautions he takes to avoid erroneous identification of the parties or mislabeling of the blood samples.

In October, 1974, Dr. Rosenthal repeated his tests after learning that the tests conducted by two other doctors contradicted his results. His additional tests produced the same exclusionary result each time they were done. The explanation given by Dr. Rosenthal for the difference between his test results and those of the other doctors was that he used a [688]*688weaker anti-N reagent than did the other two doctors. According to Dr. Rosenthal, the serum, or reagent, which he used was obtained commercially, whereas the sera used by those doctors he termed "super-specialists” were made by the doctors themselves and were more sensitive and therefore more accurate.6 Dr. Rosenthal testified further that if more sensitive sera were to be used in lieu of commercial sera in all blood tests made by court order, the results in many cases would be different.7

The petitioner called Dr. Alexander S. Wiener as her witness and respondent conceded his qualifications as an expert. Dr. Wiener is one of the foremost hematologists and serologists in the country, and a pioneer in the development and use of blood grouping tests in disputed paternity proceedings.8 Dr. Wiener testified that he has done thousands of blood grouping tests, about three fourths of which were ordered by the Family Court.

Dr. Wiener identified his report, which did not exclude respondent, and described the tests he had performed on the blood of petitioner, respondent and the infant. At the time the tests were performed, Dr. Wiener had not known of the previous test conducted by Dr. Rosenthal. Dr. Wiener testified that he used sera he had made himself which were more sensitive and of higher quality than sera available commercially. Dr. Wiener stated that there was more chance for an erroneous result with commercial sera and therefore he makes his own. According to Dr. Wiener, commercial sera contain fewer antibodies, have a slower reaction time and are generally of lower caliber. He testified that Dr. Rosenfield, who performed the third blood grouping test on these parties, also makes his own sera. Dr. Wiener described the method he [689]*689uses in running control tests on blood samples of known specificities so that errors are precluded. He further testified that the child herein had a rare subtype of the factor N, namely N2, but that his nonexclusionary results were reached without this information, which was given to him later by Dr. Rosenfield and which he independently verified. Lastly, Dr. Wiener testified that it was possible to predict the probability that respondent was the father, but that he had not made such a computation.9

After considering the four blood grouping test reports and the expert testimony of two serologists, the court holds that respondent cannot be excluded as the father of petitioner’s child. The doctor who performed the first test conceded that his exclusionary result may have been an error caused by the use of reagents which were weaker and less sensitive than those used in the subsequent, nonexclusionary tests, and he signed a later report in which he concurred with the nonexclusionary result.

The court, finding that respondent cannot be excluded, is bound by section 532 of the Family Court Act, discussed supra, to disregard the nonexclusionary blood test results and to consider only the proof adduced by the parties.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

D'Elia v. Douglas B.
138 Misc. 2d 370 (NYC Family Court, 1988)
Cheryl B. v. Alfred W. D.
99 Misc. 2d 1085 (New York Family Court, 1979)
People v. Emmons
99 Misc. 2d 941 (New York County Courts, 1979)

Cite This Page — Counsel Stack

Bluebook (online)
82 Misc. 2d 684, 369 N.Y.S.2d 291, Counsel Stack Legal Research, https://law.counselstack.com/opinion/torino-v-cruz-nycfamct-1975.